MARKET

SCNX

SCNX

Scienture Holdings, Inc
NASDAQ
0.8900
-0.0100
-1.11%
After Hours: 0.9000 +0.01 +1.12% 19:49 05/22 EDT
OPEN
0.8550
PREV CLOSE
0.9000
HIGH
0.9000
LOW
0.8165
VOLUME
117.79K
TURNOVER
--
52 WEEK HIGH
22.18
52 WEEK LOW
0.6900
MARKET CAP
11.67M
P/E (TTM)
-0.2404
1D
5D
1M
3M
1Y
5Y
1D
Scienture appoints Hariharan, Mani as co-CEOs
TipRanks · 1d ago
Scienture Holdings, Inc. Announces Leadership Transition as Suren Ajjarapu Steps Down as CEO and Chairman
NASDAQ · 1d ago
*Scienture Holdings: Mani Was President of Scienture, LLC, Subsidiary of Co >SCNX
Dow Jones · 1d ago
*Scienture Holdings: Hariharan Was Pres, CEO of Scienture Inc Prior to Its Merger With Co in 2024 >SCNX
Dow Jones · 1d ago
*Scienture Holdings: Ajjarapu to Remain as Advisor to Bd >SCNX
Dow Jones · 1d ago
*Scienture Holdings: Narasimhan Mani Appointed Pres, Co-CEO, Member of Bd >SCNX
Dow Jones · 1d ago
*Scienture Holdings: Shankar Hariharan Appointed Executive Chmn of BOD, Co-CEO >SCNX
Dow Jones · 1d ago
SCIENTURE HOLDINGS INC - NARASIMHAN MANI APPOINTED PRESIDENT AND CO-CEO
Reuters · 1d ago
More
About SCNX
Scienture Holdings, Inc., through its wholly owned subsidiary, Scienture, LLC, is a specialty pharmaceutical company focused on providing enhanced value to patients, physicians and caregivers by offering specialty products to satisfy unmet market needs. Scienture, LLC is focused on developing and commercializing products for the treatment of central nervous system and cardiovascular diseases. Scienture LLC is developing a range of product candidates, including new potential treatments for hypertension, migraine, pain and thrombosis and other related disorders. The Company's product candidates include SCN- 102 (hypertension), SCN- 104 (CNS-Pain), SCN- 106 (Cardiovascular) and SCN- 107 (Pain). SCN-102 is an oral liquid formulation of losartan potassium in development for the treatment of hypertension. SCN-104 is a multi-dose pen-based delivery system for self-injection and increased patient convenience, which is in development for the acute treatment of migraine headaches.

Webull offers Scienture Holdings Inc stock information, including NASDAQ: SCNX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SCNX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SCNX stock methods without spending real money on the virtual paper trading platform.